Fondaparinux Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Fondaparinux Sodium Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status No longer listed by FDA. The shortage was first posted on Sep 29, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 0781-3476-95
- Dosage Form
- Injection
- Presentation
- Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95)
- Initial Posting
- Sep 29, 2025